Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

Clicks: 408
ID: 117158
2009
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
: After 6 months of HAART, more than half of previously immunized children still lacked positive measles antibody. With increased use of HAART in pediatric populations, revaccination against measles and tetanus should be considered to boost response rates and immunization coverage.
Reference Key
c2009theimmune Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Farquhar C;Wamalwa D;Selig S;John-Stewart G;Mabuka J;Majiwa M;Sutton W;Haigwood N;Wariua G;Lohman-Payne B;;
Journal the pediatric infectious disease journal
Year 2009
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19258919
Keywords
immunization National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine statistical research support female male N.I.H. Extramural Child preschool Antibodies hiv-1* Cohort Studies anti-hiv agents / therapeutic use kenya immunoglobulin g / blood data interpretation bacterial / blood antiretroviral therapy hiv infections / immunology* measles vaccine / immunology* highly active* hiv infections / drug therapy* tetanus toxoid / immunology* measles vaccine / administration & dosage tetanus toxoid / administration & dosage pmid:19258919 pmc2779204 doi:10.1097/inf.0b013e3181903ed3 carey farquhar dalton wamalwa barbara lohman-payne secondary

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.